Sale!

Immunophenotyping by Flow Cytometry IgG Heavy Chain Surface Test

Original price was: $112.Current price is: $88.

-21%

The Immunophenotyping by Flow Cytometry IgG Heavy Chain Surface Test is a sophisticated diagnostic procedure that analyzes B-cell surface markers to detect various hematological malignancies and immune disorders. This test specifically identifies IgG heavy chain expression on B-lymphocytes, providing crucial information for diagnosing conditions like multiple myeloma, B-cell lymphomas, and immunodeficiency disorders. By examining cell surface proteins through advanced flow cytometry technology, healthcare providers can accurately classify blood cancers and monitor treatment response. The test requires blood or bone marrow samples and delivers same-day results for prompt clinical decision-making. Available for just $88 USD, this comprehensive analysis helps guide personalized treatment strategies and improve patient outcomes through precise cellular characterization.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

Immunophenotyping by Flow Cytometry IgG Heavy Chain Surface Test

Comprehensive Introduction to IgG Heavy Chain Surface Testing

The Immunophenotyping by Flow Cytometry IgG Heavy Chain Surface Test represents a cutting-edge diagnostic approach in modern hematology and oncology. This sophisticated laboratory analysis provides clinicians with detailed information about B-cell populations and their surface marker expression patterns. By specifically detecting IgG heavy chain molecules on lymphocyte surfaces, this test enables precise characterization of immune cell abnormalities that often indicate serious hematological conditions.

Flow cytometry immunophenotyping has revolutionized the diagnosis and monitoring of blood cancers and immune disorders. The technology utilizes laser-based detection systems to analyze thousands of cells per second, providing comprehensive data about cell size, granularity, and surface protein expression. The IgG heavy chain surface test specifically focuses on B-cell lineage markers, offering invaluable insights for hematologists and oncologists managing complex cases.

What This Advanced Test Measures and Detects

The Immunophenotyping by Flow Cytometry IgG Heavy Chain Surface Test provides detailed analysis of several critical cellular markers:

  • IgG Heavy Chain Expression: Detects the presence and density of IgG immunoglobulin heavy chains on B-cell surfaces
  • B-cell Lineage Markers: Identifies CD19, CD20, and other B-cell specific antigens
  • Maturation Patterns: Analyzes the developmental stage of B-lymphocytes
  • Clonality Assessment: Determines whether B-cell populations are monoclonal (suggesting malignancy) or polyclonal
  • Surface Marker Density: Measures the intensity of surface protein expression for diagnostic classification

Clinical Detection Capabilities

This comprehensive test can identify:

  • Multiple myeloma and plasma cell disorders
  • B-cell lymphomas including follicular lymphoma and diffuse large B-cell lymphoma
  • Chronic lymphocytic leukemia (CLL)
  • Immunodeficiency conditions affecting B-cell function
  • Post-transplant lymphoproliferative disorders
  • Minimal residual disease monitoring

Who Should Consider This Diagnostic Test

This specialized test is recommended for individuals presenting with specific clinical indications:

Symptoms and Clinical Scenarios

  • Unexplained lymphadenopathy (swollen lymph nodes) persisting for more than 2-3 weeks
  • Unexplained fever, night sweats, or significant weight loss without clear cause
  • Abnormal complete blood count (CBC) showing elevated lymphocyte counts
  • Bone pain, particularly in the back or ribs, suggesting possible myeloma
  • Recurrent infections suggesting possible immunodeficiency
  • Monitoring known hematological malignancies during treatment
  • Evaluation of abnormal protein levels detected in serum protein electrophoresis

High-Risk Patient Groups

  • Patients with family history of hematological cancers
  • Individuals with autoimmune conditions requiring immunosuppressive therapy
  • Post-transplant patients developing new symptoms
  • Patients with monoclonal gammopathy of undetermined significance (MGUS)

Significant Benefits of IgG Heavy Chain Surface Testing

Choosing the Immunophenotyping by Flow Cytometry IgG Heavy Chain Surface Test offers multiple clinical advantages:

Diagnostic Precision

  • Accurate Classification: Provides definitive diagnosis and subclassification of B-cell malignancies
  • Early Detection: Identifies hematological disorders at earlier, more treatable stages
  • Therapeutic Guidance: Informs treatment selection based on specific surface marker profiles
  • Prognostic Information: Offers insights into disease aggressiveness and likely clinical course

Clinical Management Advantages

  • Treatment Monitoring: Tracks response to therapy and detects early relapse
  • Minimal Residual Disease Detection: Identifies small numbers of remaining cancer cells after treatment
  • Personalized Medicine: Enables targeted therapy approaches based on individual marker expression
  • Comprehensive Assessment: Provides multi-parameter analysis beyond basic pathology

Understanding Your Test Results

Interpreting Immunophenotyping by Flow Cytometry results requires specialized expertise, but here’s general guidance:

Normal Results

  • Polyclonal B-cell population with diverse surface marker expression
  • Appropriate IgG heavy chain distribution across B-cell subsets
  • Normal maturation patterns without evidence of clonal expansion

Abnormal Findings

  • Monoclonal Population: Suggests malignant transformation requiring further evaluation
  • Aberrant Marker Expression: May indicate specific lymphoma subtypes
  • Abnormal IgG Expression: Could suggest plasma cell disorders or immunodeficiency
  • Altered Maturation Patterns: May indicate developmental abnormalities or early malignancy

Clinical Correlation

Your healthcare provider will correlate flow cytometry findings with:

  • Clinical symptoms and physical examination findings
  • Other laboratory test results including complete blood count and serum protein studies
  • Imaging studies when indicated
  • Bone marrow biopsy results if performed

Test Pricing and Availability

Price Type Amount (USD)
Discount Price $88
Regular Price $112

Turnaround Time and Sample Requirements

  • Reporting Time: Same-day results when samples received by 9 AM
  • Sample Types: 3 mL whole blood in EDTA tube AND 3 mL whole blood in Sodium Heparin tube OR 2 mL bone marrow in Sodium Heparin tube
  • Shipping Instructions: Immediate shipment at 18-22°C – DO NOT REFRIGERATE OR FREEZE
  • Required Information: Complete clinical history and collection details on test request form

Nationwide Availability and Booking

We have diagnostic centers conveniently located throughout the United States, serving patients in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our state-of-the-art flow cytometry laboratories maintain the highest standards of accuracy and reliability.

Take Action for Your Health

Don’t wait to address concerning symptoms or monitor your hematological health. Our expert team of hematologists, oncologists, and flow cytometry specialists are ready to provide you with comprehensive diagnostic services. With same-day results and competitive pricing at just $88 USD, there’s no reason to delay this important health assessment.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your Immunophenotyping by Flow Cytometry IgG Heavy Chain Surface Test. Our patient coordinators will help you find the most convenient location and answer any questions about the testing process. Early detection and accurate diagnosis are crucial for successful treatment outcomes – take the first step toward better health today.